Jesús Frías
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 10
- Antibiotics Pharmacokinetics and Efficacy 9
- Drug-Induced Adverse Reactions 5
- Toxicology top 2%
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism 10
- Antibiotics Pharmacokinetics and Efficacy 9
- Drug-Induced Adverse Reactions 5
- Gastroenterology top 10%
- Geriatrics and Gerontology top 10%
-
- Pharmaceutical studies and practices 10
-
- Poisoning and overdose treatments 7
-
- Analytical Methods in Pharmaceuticals 6
-
- Cardiac electrophysiology and arrhythmias 5
-
- Statistical Methods in Clinical Trials 5
- Co-authors
- Antonio J. CarcasElena Ramı́rezAlberto M. BorobiaAntonio G. Garcı́aLuis Gandı́aJuan A. ReigSalvador ViniegraF. Sala
- Cited by
- PharmacologyToxicology
- Journals
- Nature (1 paper)SHILAP Revista de lepidopterología (2 papers)PLoS ONE (2 papers)
- Partner nations
- SpainUnited StatesAustria
In The Last Decade
Jesús Frías
68 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 118
- Pharmacology 229
- Toxicology 85
- Pharmacology 228
- Gastroenterology 67
- Geriatrics and Gerontology 47
Countries citing papers authored by Jesús Frías
This map shows the geographic impact of Jesús Frías's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Frías with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Frías more than expected).
Fields of papers citing papers by Jesús Frías
This network shows the impact of papers produced by Jesús Frías. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Frías. The network helps show where Jesús Frías may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jesús Frías, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 5 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 2 | |
| 8 | 2021 | 18 | |
| 9 | Prevalencia de factores de riesgo cardiovascular en trabajadores de un hospital terciario de Madrid | 2020 | 2 |
| 10 | 2020 | 16 | |
| 11 | 2020 | 19 | |
| 12 | 2018 | 20 | |
| 13 | 2014 | 48 | |
| 14 | Desarrollo y validación de un programa de toxicovigilancia con detección automatizada de casos en un hopital terciario (SAT-HULP) | 2013 | 3 |
| 15 | 2013 | 10 | |
| 16 | ESTUDIOS DE BIOEQUIVALENCIA: LA NECESIDAD DE ESTABLECER LA FIABILIDAD DE LOS MEDICAMENTOS GENÉRICOS | 2009 | 4 |
| 17 | 2009 | 61 | |
| 18 | 2009 | 37 | |
| 19 | 2001 | 10 | |
| 20 | 1994 | 5 |
About Jesús Frías
Jesús Frías is a scholar working on Toxicology, Pharmacology and Applied Microbiology and Biotechnology, having authored 75 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (10 papers), Pharmaceutical studies and practices (10 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers), Poisoning and overdose treatments (7 papers), Analytical Methods in Pharmaceuticals (6 papers), Drug-Induced Adverse Reactions (5 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Statistical Methods in Clinical Trials (5 papers). The work is most often cited by research in Pharmacology (229 citations), Toxicology (85 citations) and Pharmacology (228 citations). Jesús Frías has collaborated with scholars based in Spain, United States and Austria. Frequent co-authors include Antonio J. Carcas, Elena Ramı́rez, Alberto M. Borobia, Antonio G. Garcı́a, Luis Gandı́a, Juan A. Reig, Salvador Viniegra, F. Sala, Rosalba I. Fonteríz and Hoi Y. Tong. Their work appears in journals such as Nature, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.